Sort
10,766 grants matching “checkpoint inhibitor”
E2F AND THE CONTROL OF APOPTOSIS
$201,550Ohio State University · R01 · FY2003 · CA
E2F AND THE CONTROL OF APOPTOSIS
$201,362Ohio State University · R01 · FY2000 · CA
Finding the optimal balance of immunotherapy efficacy and toxicity.
$201,354David Eric Gerber · Ut Southwestern Medical Center · U01 · FY2021 · AI
Role of Polo-like kinase (Plk-1) in Hepatitis B Virus-mediated Hepatocellular Car
$201,300Ourania M. Andrisani · Purdue University · R21 · FY2009 · CA
CYTOKINE SIGNALING PATHWAYS REGULATING A G1 CHECKPOINT
$201,283University Of Iowa · R01 · FY2002 · CA
Development of Methods for Precise MR-guided Hyperthermia Delivery for Targeted Cancer Therapies
$201,251Eugene Ozhinsky · University Of California, San Francisco · R21 · FY2020 · EB
TET2 Regulation of CD8 T cell differentiation During Chronic Viral Infection
$201,250Martha S Jordan · University Of Pennsylvania · R21 · FY2020 · AI
Mechanisms and strategies to rescue suboptimal T cell priming in colon cancer
$201,042Peter Maxwell Kienitz Westcott · Cold Spring Harbor Laboratory · K22 · FY2023 · CA
Mechanisms and strategies to rescue suboptimal T cell priming in colon cancer
$201,042Peter Maxwell Kienitz Westcott · Cold Spring Harbor Laboratory · K22 · FY2025 · CA
Mechanisms and strategies to rescue suboptimal T cell priming in colon cancer
$201,042Peter Maxwell Kienitz Westcott · Cold Spring Harbor Laboratory · K22 · FY2024 · CA
Systems biology dissection of the road to T cell exhaustion within the tumor microenvironment to identify novel targets for tumor immunotherapy
$200,970Ann B Hill · Oregon Health & Science University · R21 · FY2018 · CA
Directing Cancer Immunotherapy with Real-Time ImmunoPET
$200,970Wei-Zen Wei · Wayne State University · R21 · FY2017 · CA
Determining how autophagy mediates resistance to cancer therapies
$200,970George Victor Thomas · Oregon Health & Science University · R21 · FY2018 · CA
Overcoming resistance to cancer immunotherapy by targeting MDSC-derived adenosine
$200,970Kavitha Yaddanapudi · University Of Louisville · R21 · FY2020 · CA
Disrupting macrophage metabolism to reduce immunosuppression and enhance therapy in pancreatic cancer
$200,933Christopher J. Halbrook · University Of California-Irvine · R00 · FY2021 · CA
T cells in the aging brain
$200,720Anne Brunet · Stanford University · R01 · FY2024 · AG
Immune checkpoint Inhibitor-Induced Autoimmune Diabetes: Immunological Mechanisms and Biomarker Discovery in Provoked Beta Cell Autoimmunity
$200,664Zoe Quandt · University Of California, San Francisco · K08 · FY2025 · AI
RADIATION INDUCED G1 CHECKPOINT ARREST IN YEAST
$200,632University Of Chicago · R01 · FY2001 · GM
DC AML Fusion Cell Vaccination with Immune checkpoint Blockade
$200,370Gordon James Freeman · Dana-Farber Cancer Inst · P50 · FY2020 · CA
A novel IL-2 biologic and tumor immunity
$200,318Thomas R Malek · University Of Miami School Of Medicine · R21 · FY2017 · CA
Development of Methods for Precise MR-guided Hyperthermia Delivery for Targeted Cancer Therapies
$200,313Eugene Ozhinsky · University Of California, San Francisco · R21 · FY2019 · EB
Structural studies of molecular cancer targets and drug development
$200,194David S Waugh · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
NOVEL HUMORAL AND CELLULAR BIOMARKERS OF AUTOIMMUNE DISEASES CAUSED BY IMMUNOTHERAPY
$200,107Hyun-Sung Lee · Baylor College Of Medicine · R21 · FY2024 · AI
Ipilimumab as an adjuvant for HIV vaccines
$200,007Mauricio De Aguiar Martins · University Of Miami School Of Medicine · K01 · FY2018 · OD
An Engineered Nanoimmunotherapy for Melanoma
$200,001Elizabeth E Sweeney · Immunoblue, Llc · R41 · FY2018 · CA